Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | 11 | 1 | 4 | 0 | €44.22 | €49.02 | 10.850% |
| Stratec SE | 2 | 0 | 0 | 0 | €42.70 | - | - |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.14 | €11.05 | 251.860% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 3 | 1 | €4.70 | €12.80 | 172.372% |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €12.43 | €27.00 | 117.185% |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
| Twist Bioscience Corp | 4 | 0 | 1 | 0 | €29.89 | €40.70 | 36.181% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €93.00 | €108.77 | 16.955% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.47 | €7.00 | 101.845% |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.50 | €5.00 | 11.111% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €42.40 | - | - |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €70.36 | €100.00 | 42.126% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €342.00 | €310.00 | -9.357% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| WAVE Life Sciences Ltd | 8 | 0 | 1 | 0 | €4.52 | €9.10 | 101.345% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 1 | €40.00 | €50.00 | 25.000% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
| XOMA Corp. | 5 | 0 | 2 | 0 | €23.60 | €68.62 | 190.764% |